Protagenic Therapeutics Inc (PTIX)

$2.03 -0.07 (-3.33%)
Market Cap 3.91M
Revenue (ttm) 0.00
Net Income (ttm) -5.53M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 23,800
Avg Vol 90,720
Day's Range N/A - N/A
Shares Out 1.93M
Stochastic %K 43%
Beta 0.35
Analysts Strong Buy
Price Target $4.00

Company Profile

Protagenic Therapeutics, Inc. operates as a pharmaceutical company specializing in the development of medicines manufactured from cannabinoid and cannabinoid-like molecules. Protagenic Therapeutics, Inc. was founded in 2004 and is based in Santa Barbara, California.

Industry: Biotechnology
Sector: Healthcare
Phone: (805) 699-5596
Address:
701 Anacapa Street, Suite C, Santa Barbara, United States
MS1974
MS1974 Nov. 14 at 11:58 AM
$PTIX Today to the moon🚀🚀🚀🚀🚀
0 · Reply
MS1974
MS1974 Nov. 14 at 11:16 AM
$PTIX Prepare🧐🧐🧐🚀🚀🚀
0 · Reply
GetOverHere_
GetOverHere_ Nov. 14 at 8:35 AM
$DHI $KDK $PTIX $CLOV `
0 · Reply
JL_TradeZ
JL_TradeZ Nov. 14 at 2:21 AM
Final Watchlist 14/11 $AKAN Low float name waking up after the license update. AH volume came in and any morning push can send it. Watching 1.40+ for continuation $TNMG Big volume on the Coupang news but faded. Can still get a day-two move if it reclaims 0.40 with strength $PTIX Tiny float curling after the Phase 1 update. Dilution risk is heavy so it’s scalp-only. Needs 2.15–2.20 to open up for more upside $WTO Oversold R/S bounce setup. Big volume today and basing around 0.02. Needs 0.0225+ for momentum toward 0.024–0.026 $DGXX Held 3.60 support after the earnings dump. Watching a reclaim of 3.90–4.00 for a bounce toward mid 4s
1 · Reply
topstockalerts
topstockalerts Nov. 13 at 8:29 PM
Protagenic Therapeutics shares rose Thursday after the biopharma company completed enrollment and dosing in its Phase 1 Multiple Ascending Dose (MAD) study for lead compound PT00114. The trial assessed safety and tolerability in healthy volunteers receiving multiple doses over time. The company plans to release a full safety analysis summary by the end of the month, with primary MAD study results expected before November 30. PT00114 is being developed as a potential first-in-class therapeutic aimed at restoring resilience and balance in individuals affected by chronic stress and related neurological issues. $PTIX
0 · Reply
MS1974
MS1974 Nov. 13 at 7:12 PM
$PTIX Booom 🚀🚀🚀💥
0 · Reply
isaacwilliams33
isaacwilliams33 Nov. 13 at 4:47 PM
$CYCU $LITP $DTCK $PTIX
0 · Reply
isaacwilliams33
isaacwilliams33 Nov. 13 at 4:41 PM
$PTIX .
0 · Reply
MS1974
MS1974 Nov. 13 at 2:40 PM
$PTIX this can fly anytime now.🚀🚀🚀
0 · Reply
SwingTraderra
SwingTraderra Nov. 13 at 1:43 PM
$PTIX if the results are good this could have a parabolic move
0 · Reply
Latest News on PTIX
Protagenic Therapeutics Announces Completion of Enrollment and Dosing in Phase 1 MAD Study

Nov 13, 2025, 8:22 AM EST - 3 days ago

Protagenic Therapeutics Announces Completion of Enrollment and Dosing in Phase 1 MAD Study

Protagenic Therapeutics Provides Update on Form 10-Q Filing Timeline and Nasdaq Compliance

Aug 22, 2025, 5:25 PM EDT - 3 months ago

Protagenic Therapeutics Provides Update on Form 10-Q Filing Timeline and Nasdaq Compliance

Protagenic Therapeutics Advances PT00114 into Multiple-Dose Phase 1 Trial; Positioning for Phase 2 in Stress & Mood Disorders

Aug 21, 2025, 8:12 AM EDT - 3 months ago

Protagenic Therapeutics Advances PT00114 into Multiple-Dose Phase 1 Trial; Positioning for Phase 2 in Stress & Mood Disorders

Protagenic Therapeutics Receives $3.1 Million from Recent Warrant Activity

May 21, 2025, 9:15 AM EDT - 6 months ago

Protagenic Therapeutics Receives $3.1 Million from Recent Warrant Activity

Gold Gains Over 1%; Protagenic Therapeutics Shares Spike Higher

May 19, 2025, 1:40 PM EDT - 6 months ago

Gold Gains Over 1%; Protagenic Therapeutics Shares Spike Higher

Protagenic Therapeutics and Phytanix Announce Business Combination to form Neuroactive Biopharmaceutical Company with Six Drug Candidates in Development including Treatments for Obesity and Metabolic Disorders

May 19, 2025, 7:43 AM EDT - 6 months ago

Protagenic Therapeutics and Phytanix Announce Business Combination to form Neuroactive Biopharmaceutical Company with Six Drug Candidates in Development including Treatments for Obesity and Metabolic Disorders

Protagenic Therapeutics to Effect 1-for-14 Reverse Stock Split

Apr 29, 2025, 4:00 PM EDT - 7 months ago

Protagenic Therapeutics to Effect 1-for-14 Reverse Stock Split

Protagenic Therapeutics Announces Closing of Private Placement for Aggregate Gross Proceeds of $1.275 Million

Nov 5, 2024, 8:12 AM EST - 1 year ago

Protagenic Therapeutics Announces Closing of Private Placement for Aggregate Gross Proceeds of $1.275 Million

Protagenic Therapeutics Announces Pricing of Private Placement for Aggregate Gross Proceeds of $1.275 Million

Oct 29, 2024, 9:27 AM EDT - 1 year ago

Protagenic Therapeutics Announces Pricing of Private Placement for Aggregate Gross Proceeds of $1.275 Million

Protagenic Therapeutics Completes Enrollment in Single Dose Portion of Phase 1 of Innovative Stress Disorder Trial

May 1, 2024, 8:38 AM EDT - 1 year ago

Protagenic Therapeutics Completes Enrollment in Single Dose Portion of Phase 1 of Innovative Stress Disorder Trial

Protagenic Therapeutics' Innovative Peptide PT00114 to be Highlighted at Boston Summit

Apr 17, 2024, 8:42 AM EDT - 1 year ago

Protagenic Therapeutics' Innovative Peptide PT00114 to be Highlighted at Boston Summit

Protagenic Therapeutics, Inc. (PTIX) Q4 2023 Earnings Call Transcript

Apr 1, 2024, 9:32 PM EDT - 1 year ago

Protagenic Therapeutics, Inc. (PTIX) Q4 2023 Earnings Call Transcript

Protagenic Therapeutics Reports Fourth Quarter and Full Year 2023 Results

Apr 1, 2024, 4:20 PM EDT - 1 year ago

Protagenic Therapeutics Reports Fourth Quarter and Full Year 2023 Results

Protagenic Therapeutics Successfully Concludes Third Cohort in Single Dose Portion of Phase 1 Trial for Stress-Related Neuropsychiatric Disorders

Mar 27, 2024, 8:42 AM EDT - 1 year ago

Protagenic Therapeutics Successfully Concludes Third Cohort in Single Dose Portion of Phase 1 Trial for Stress-Related Neuropsychiatric Disorders

Protagenic Therapeutics Schedules First Q4 and FY 2023 Earnings Call

Mar 25, 2024, 5:00 PM EDT - 1 year ago

Protagenic Therapeutics Schedules First Q4 and FY 2023 Earnings Call

Protagenic Therapeutics Announces Resolution of Nasdaq Deficiency Notice

Mar 21, 2024, 8:41 AM EDT - 1 year ago

Protagenic Therapeutics Announces Resolution of Nasdaq Deficiency Notice

Protagenic Therapeutics Achieves First Clinical Safety Milestone with its Novel Neuropeptide for the Potential Treatment of Stress-Related Disorders

Feb 13, 2024, 8:30 AM EST - 1 year ago

Protagenic Therapeutics Achieves First Clinical Safety Milestone with its Novel Neuropeptide for the Potential Treatment of Stress-Related Disorders

Protagenic Therapeutics Announces Date of Annual Shareholder Meeting

Oct 13, 2023, 9:00 AM EDT - 2 years ago

Protagenic Therapeutics Announces Date of Annual Shareholder Meeting

Protagenic Therapeutics Initiates Phase I/IIa Clinical Trial for Groundbreaking Brain Peptide PT00114

Sep 26, 2023, 8:18 AM EDT - 2 years ago

Protagenic Therapeutics Initiates Phase I/IIa Clinical Trial for Groundbreaking Brain Peptide PT00114

Protagenic Therapeutics to Effect 1-for-4 Reverse Stock Split

Mar 22, 2023, 12:55 PM EDT - 2 years ago

Protagenic Therapeutics to Effect 1-for-4 Reverse Stock Split

Protagenic Therapeutics to Present at the B. Riley Securities Neuro and Ophthalmology Virtual Investor Conference on April 27th

Apr 26, 2022, 8:15 AM EDT - 3 years ago

Protagenic Therapeutics to Present at the B. Riley Securities Neuro and Ophthalmology Virtual Investor Conference on April 27th

Protagenic Therapeutics Announces Third Quarter 2021 Results and Business Update

Nov 16, 2021, 9:58 AM EST - 4 years ago

Protagenic Therapeutics Announces Third Quarter 2021 Results and Business Update

Protagenic Therapeutics to Host Virtual Science Review Wednesday, September 8th at 10 AM ET

Aug 30, 2021, 9:15 AM EDT - 4 years ago

Protagenic Therapeutics to Host Virtual Science Review Wednesday, September 8th at 10 AM ET

Protagenic Therapeutics Announces Second Quarter 2021 Results and Provides Business Update

Aug 17, 2021, 7:45 AM EDT - 4 years ago

Protagenic Therapeutics Announces Second Quarter 2021 Results and Provides Business Update

Protagenic Therapeutics To Start Clinical Trials For Depression Candidate By 2021 End

Jul 26, 2021, 6:31 AM EDT - 4 years ago

Protagenic Therapeutics To Start Clinical Trials For Depression Candidate By 2021 End

Protagenic Therapeutics Updates Timeline for Commencement of Patient Enrollment for PT00114 Clinical Trial

Jul 23, 2021, 4:21 PM EDT - 4 years ago

Protagenic Therapeutics Updates Timeline for Commencement of Patient Enrollment for PT00114 Clinical Trial

Protagenic Therapeutics to Host Webinar with Dr. Maurizio Fava for its Lead Molecule PT00114 on Tuesday, July 13th at 10:00 AM ET

Jul 6, 2021, 6:17 AM EDT - 4 years ago

Protagenic Therapeutics to Host Webinar with Dr. Maurizio Fava for its Lead Molecule PT00114 on Tuesday, July 13th at 10:00 AM ET

Protagenic Therapeutics to Present at the H.C. Wainwright Psychedelics in Psychiatry and Beyond Virtual Conference on June 17th

Jun 16, 2021, 9:15 AM EDT - 4 years ago

Protagenic Therapeutics to Present at the H.C. Wainwright Psychedelics in Psychiatry and Beyond Virtual Conference on June 17th

Protagenic Therapeutics, Inc. Announces Closing of $13.2 Million Public Offering and Uplisting to Nasdaq

Apr 29, 2021, 3:06 PM EDT - 4 years ago

Protagenic Therapeutics, Inc. Announces Closing of $13.2 Million Public Offering and Uplisting to Nasdaq

Protagenic Therapeutics, Inc. Announces Nasdaq Uplisting and Pricing of $13.2 Million Public Offering

Apr 26, 2021, 8:58 PM EDT - 4 years ago

Protagenic Therapeutics, Inc. Announces Nasdaq Uplisting and Pricing of $13.2 Million Public Offering

MS1974
MS1974 Nov. 14 at 11:58 AM
$PTIX Today to the moon🚀🚀🚀🚀🚀
0 · Reply
MS1974
MS1974 Nov. 14 at 11:16 AM
$PTIX Prepare🧐🧐🧐🚀🚀🚀
0 · Reply
GetOverHere_
GetOverHere_ Nov. 14 at 8:35 AM
$DHI $KDK $PTIX $CLOV `
0 · Reply
JL_TradeZ
JL_TradeZ Nov. 14 at 2:21 AM
Final Watchlist 14/11 $AKAN Low float name waking up after the license update. AH volume came in and any morning push can send it. Watching 1.40+ for continuation $TNMG Big volume on the Coupang news but faded. Can still get a day-two move if it reclaims 0.40 with strength $PTIX Tiny float curling after the Phase 1 update. Dilution risk is heavy so it’s scalp-only. Needs 2.15–2.20 to open up for more upside $WTO Oversold R/S bounce setup. Big volume today and basing around 0.02. Needs 0.0225+ for momentum toward 0.024–0.026 $DGXX Held 3.60 support after the earnings dump. Watching a reclaim of 3.90–4.00 for a bounce toward mid 4s
1 · Reply
topstockalerts
topstockalerts Nov. 13 at 8:29 PM
Protagenic Therapeutics shares rose Thursday after the biopharma company completed enrollment and dosing in its Phase 1 Multiple Ascending Dose (MAD) study for lead compound PT00114. The trial assessed safety and tolerability in healthy volunteers receiving multiple doses over time. The company plans to release a full safety analysis summary by the end of the month, with primary MAD study results expected before November 30. PT00114 is being developed as a potential first-in-class therapeutic aimed at restoring resilience and balance in individuals affected by chronic stress and related neurological issues. $PTIX
0 · Reply
MS1974
MS1974 Nov. 13 at 7:12 PM
$PTIX Booom 🚀🚀🚀💥
0 · Reply
isaacwilliams33
isaacwilliams33 Nov. 13 at 4:47 PM
$CYCU $LITP $DTCK $PTIX
0 · Reply
isaacwilliams33
isaacwilliams33 Nov. 13 at 4:41 PM
$PTIX .
0 · Reply
MS1974
MS1974 Nov. 13 at 2:40 PM
$PTIX this can fly anytime now.🚀🚀🚀
0 · Reply
SwingTraderra
SwingTraderra Nov. 13 at 1:43 PM
$PTIX if the results are good this could have a parabolic move
0 · Reply
MS1974
MS1974 Nov. 13 at 1:31 PM
$PTIX Watch this on!🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀
0 · Reply
makedatbread88
makedatbread88 Nov. 13 at 1:26 PM
$PTIX news out keep an eye! Low floater!
1 · Reply
327JoseF
327JoseF Nov. 12 at 9:44 PM
$PTIX who has an explanation for why this is down? Is there a chance of a pump upcoming in anyone’s thoughts?
2 · Reply
veryboredXYZ
veryboredXYZ Nov. 12 at 1:56 AM
$PTIX gonna load up for the good ole bounce once this goes to 1.90
1 · Reply
Manitou1
Manitou1 Nov. 11 at 3:46 PM
$PTIX
0 · Reply
MS1974
MS1974 Nov. 11 at 3:04 PM
$PTIX POS. moment on the radar🧐🚀
0 · Reply
MS1974
MS1974 Nov. 10 at 6:59 PM
$PTIX bk
1 · Reply
ka1954
ka1954 Nov. 10 at 3:24 PM
$PTIX piece of crap
0 · Reply
16Zx10r
16Zx10r Nov. 10 at 3:13 AM
$PTIX Maybe a pop to the EMA200 soon... bounced off bottom bollinger, EMA5 will confirm IMO... Ill conservative with $4.00. SL $1.80. Need above 2.15, then 2.59, 3.70, then $4
0 · Reply
327JoseF
327JoseF Nov. 8 at 12:34 PM
$PTIX doesn’t that mean it can be driven up easily also?
1 · Reply
ItsComingBaby
ItsComingBaby Nov. 6 at 5:24 PM
$PTIX https://www.tipranks.com/news/company-announcements/jennifer-chao-resigns-from-protagenic-therapeutics-board
0 · Reply
ka1954
ka1954 Nov. 6 at 5:11 PM
$PTIX THIS STOCK is a joke, down 12% on 23k volume only. good luck guys
1 · Reply